Tenon Medical (TNON) Common Equity (2021 - 2026)

Tenon Medical's Common Equity history runs 6 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• On a quarterly basis, Common Equity fell 79.79% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 79.79% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, down 15.59% from the prior year.
• Common Equity declined to $1.9 million in Q1 2026 per TNON's latest filing, from $5.0 million in the prior quarter.
• Across five years, Common Equity topped out at $15.1 million in Q2 2022 and bottomed at -$22.7 million in Q1 2022.
• The 5-year median for Common Equity is $3.6 million (2024), against an average of $3.5 million.
• Across the five-year window, Common Equity plunged 682.38% in 2022 and surged 706.85% in 2025, its largest moves.
• Year by year, Common Equity stood at $6.3 million in 2022, then plunged by 87.56% to $778000.0 in 2023, then jumped by 667.48% to $6.0 million in 2024, then slipped by 15.59% to $5.0 million in 2025, then slumped by 62.4% to $1.9 million in 2026.
• Per Business Quant, the three latest TNON Common Equity figures stand at $1.9 million (Q1 2026), $5.0 million (Q4 2025), and $131000.0 (Q3 2025).